NEW YORK, Nov. 20, 2015 /PRNewswire/ -- Wolf Popper LLP is
investigating claims on behalf of investors in Liberator Medical
Holdings, Inc. ("Liberator Medical") (NYSE: LBMH), concerning the
proposed acquisition of Liberator Medical by C.R. Bard, Inc. (NYSE:
BCR). Liberator Medical shareholders seeking more information
about this acquisition can contact Carl L.
Stine at (212) 759-4600 or cstine@wolfpopper.com.
The investigation concerns whether Liberator Medical's directors
are breaching their fiduciary duties by failing to adequately
maximize shareholder value. Under the terms of the proposed
transaction, Liberator Medical's shareholders will receive
$3.35 per share in cash for each
Liberator Medical share they own. However, the offer price is
below the 52-week high of $3.87 per
share and below an analyst price target of $8.00 per share.
Wolf Popper LLP has extensive experience representing investors
in mergers and acquisition lawsuits and has successfully ensured
that investors receive the maximum compensation. Twelve Wolf
Popper attorneys were named Rising Stars or Super Lawyers in the
2015 Super Lawyers New York City Metro Edition, including
Wolf Popper partner Carl Stine, who was included in the Super
Lawyers Top 100 List for the New York
City Metro area. View Wolf Popper attorney biographies
at www.wolfpopper.com.
Attorney Advertising: Prior Results Do Not Guarantee A Similar
Outcome.
Wolf Popper LLP
845 Third Avenue
New York, New York 10022
Telephone: 212-759-4600
Toll Free Tel: 877-370-7703
Toll Free Fax: 877-370-7704
Email: cstine@wolfpopper.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/wolf-popper-llp-investigates-claims-that-the-proposed-acquisition-of-liberator-medical-holdings-inc-may-not-be-in-the-best-interests-of-its-investors-300182548.html
SOURCE Wolf Popper LLP